And here we were talking about brain cancer, and how PAT-DX1 is unique in being able to cross the blood brain barrier - there is no antibody on the market than can do that.
BUT - now we have a new indication: Pancreatic Cancer, one of the hardest cancers to treat!
26% reduction in tumor growth is a great baseline to work with for human trials.
#platform
#blockbuster
I keep saying it - the past month or so has seen massive accumulation by smart money.
.
Ann: PAT-DX1 Improves Survival in Model of Pancreatic Cancer, page-3
-
- There are more pages in this discussion • 34 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add PAB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
0.7¢ |
Change
-0.001(12.5%) |
Mkt cap ! $14.40M | |||
| Open | High | Low | Value | Volume |
| 0.7¢ | 0.7¢ | 0.7¢ | $43.28K | 6.183M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 237374 | 0.7¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 0.8¢ | 1732079 | 8 |
View Market Depth
| Last trade - 16.10pm 21/06/2024 (20 minute delay) ? |
| PAB (ASX) Chart |